Literature DB >> 20138170

Enhanced expression of lumican inhibited the attachment and growth of human embryonic kidney 293 cells.

Toshiyuki Ishiwata1, Tetsushi Yamamoto, Kiyoko Kawahara, Yoko Kawamoto, Yoko Matsuda, Shunji Ishiwata, Zenya Naito.   

Abstract

Lumican is a member of a small leucine-rich proteoglycan (SLRP) family and it regulates the assembly and diameter of collagen fibers in the extracellular matrix of various tissues. Lumican expression was reported in various kinds of tumor cells. Lumican inhibits the growth of melanoma cells, but the lumican in pancreatic cancer correlated with an advanced stage and retroperitoneal and duodenal invasion. In this study, we clarified whether the enhanced expression of lumican contributes to cellular attachment, growth, colony formation, migration and invasion. HEK 293 cell, stably transfected with lumican cDNA synthesized and secreted a 50 kDa lumican protein at high levels in culture medium. The cells showed a polygonal appearance with long projections and the degree of adhesion of the cells to fibronectin was lower than that of empty vector transfected control cells (mock cells). In contrast, the degree of adhesion of the cells to type I collagen was not different from that of mock cells. The expression levels of alpha5 integrin, the major integrin subunit for fibronectin, were lower in lumican-transfected HEK cells than in mock cells. Furthermore, lumican-transfected HEK cells showed reduced growth rates in vitro and did not form colonies in soft agar. Phosphorylation of AKT, extracellular signal-regulated kinase (ERK) 1/2 and mammalian target of rapamycin (mTOR) decreased in the lumican-transfected HEK cells. Cell migration and invasion were not altered in lumican-transfected HEK cells and mock cells. These findings indicate that the 50kDa lumican protein plays important roles in the inhibition of HEK cell attachment and growth, and it might inhibit the activation of integrin pathways. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138170     DOI: 10.1016/j.yexmp.2010.01.010

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  5 in total

1.  Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis.

Authors:  Yoko Matsuda; Zenya Naito; Kiyoko Kawahara; Nando Nakazawa; Murray Korc; Toshiyuki Ishiwata
Journal:  Cancer Biol Ther       Date:  2011-03-01       Impact factor: 4.742

2.  Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.

Authors:  Anuradha Krishnan; Xia Li; Winstonwhei-Yang Kao; Kimberly Viker; Kim Butters; Howard Masuoka; Bruce Knudsen; Gregory Gores; Michael Charlton
Journal:  Lab Invest       Date:  2012-09-24       Impact factor: 5.662

3.  Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.

Authors:  Suzanne Miyamoto; L Renee Ruhaak; Carol Stroble; Michelle R Salemi; Brett Phinney; Carlito B Lebrilla; Gary S Leiserowitz
Journal:  J Proteome Res       Date:  2016-08-23       Impact factor: 4.466

4.  Transient receptor potential melastatin 4 channel controls calcium signals and dental follicle stem cell differentiation.

Authors:  Piper Nelson; Tran Doan Ngoc Tran; Hanjie Zhang; Olga Zolochevska; Marxa Figueiredo; Ji-Ming Feng; Dina L Gutierrez; Rui Xiao; Shaomian Yao; Arthur Penn; Li-Jun Yang; Henrique Cheng
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

5.  Lumican promotes joint fibrosis through TGF-β signaling.

Authors:  Dahai Xiao; Tangzhao Liang; Ze Zhuang; Ronghan He; Jianhua Ren; Shihai Jiang; Lei Zhu; Kun Wang; Dehai Shi
Journal:  FEBS Open Bio       Date:  2020-10-25       Impact factor: 2.792

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.